Author: Tucci, Paula; Estevez, Verónica; Becco, Lorena; Cabrera-Cabrera, Florencia; Grotiuz, Germán; Reolon, Eduardo; Marín, Mónica
Title: Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen Document date: 2016_9_19
ID: 71omypkg_41
Snippet: Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial......
Document: Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.
Search related documents:
Co phrase search for related documents- bacterial cell surface and immune response: 1, 2, 3
- cell surface and effective immune response: 1, 2, 3, 4, 5
- cell surface and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- cell surface and protective immunity: 1, 2, 3, 4, 5, 6, 7
- cell surface and vaccine formulation: 1, 2, 3, 4, 5
- effective immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- effective immune response and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- effective immune response and vaccine formulation: 1
- effective immune response promote and immune response: 1, 2, 3, 4
- immune response and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- immune response and vaccine formulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- protective immunity and vaccine formulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date